Invesco Ltd. Has $303.90 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Invesco Ltd. increased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 8.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,572,567 shares of the pharmacy operator's stock after acquiring an additional 2,631,332 shares during the quarter. Invesco Ltd. owned about 3.77% of Walgreens Boots Alliance worth $303,902,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WBA. Polymer Capital Management US LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth $222,000. Russell Investments Group Ltd. raised its position in shares of Walgreens Boots Alliance by 58.8% during the fourth quarter. Russell Investments Group Ltd. now owns 345,273 shares of the pharmacy operator's stock valued at $3,218,000 after buying an additional 127,800 shares during the last quarter. Grantham Mayo Van Otterloo & Co. LLC lifted its stake in shares of Walgreens Boots Alliance by 12.3% in the fourth quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 2,974,248 shares of the pharmacy operator's stock valued at $27,750,000 after buying an additional 325,721 shares during the period. Resona Asset Management Co. Ltd. bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $2,234,000. Finally, Smith Moore & CO. lifted its position in shares of Walgreens Boots Alliance by 29.3% in the 4th quarter. Smith Moore & CO. now owns 37,151 shares of the pharmacy operator's stock worth $347,000 after acquiring an additional 8,422 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA traded up $0.02 during midday trading on Wednesday, reaching $10.87. The company's stock had a trading volume of 2,419,960 shares, compared to its average volume of 20,904,139. The business's fifty day simple moving average is $10.78 and its 200-day simple moving average is $10.10. The company has a market capitalization of $9.40 billion, a P/E ratio of -1.06, a P/E/G ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. During the same period in the prior year, the business earned $1.20 earnings per share. Walgreens Boots Alliance's quarterly revenue was up 4.1% on a year-over-year basis. As a group, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Ratings Changes

WBA has been the subject of a number of recent research reports. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Friday, April 11th. They issued a "hold" rating for the company. Evercore ISI upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research note on Monday, January 13th. Finally, Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.